Search form
Search
contact us
Navigation
home
boards
job center
job ratings
cp wire
device news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» ICON-2
ICON-2
After a long march with Cabo, Exelixis is expanding its focus with an antibody-drug conjugate deal
After a long march with Cabo, Exelixis is expanding its focus with an antibody-drug conjugate deal
Endpoints
Exelixis
Cabometyx
ICON-2
Iconic Therapeutics
antibody-drug conjugate
Flag link:
